16 - 20 December 2024 | Bangkok, Thailand
Cancer is a common disease in pets and one of the main causes of death. Over the past decade, our knowledge of cancer in animals has increased rapidly, and today several treatment options exist to treat canine and feline cancer patients.
Oncology II builds up on Oncology I and addresses some of the most common canine and feline tumours including haematopoietic neoplasms (e.g. lymphoma) and oral, gastrointestinal, pancreatic & hepatosplenic tumours. A major emphasis of the course will again be on understanding how to systematically approach a patient with cancer. There will be lots of interactive and case-oriented work using a rational approach including recognizing symptoms, interpreting radiographic findings, choosing correct staging procedures and formulating a therapeutic plan.
Oncology 1 is mandatory for taking course 2.
This course will be taught in English.
08:30 – 09:00 Welcome and registration
09:00 – 09:45 Canine lymphoma: Epidemiology, etiology, anatomical & histological forms, staging, clinical signs (Schmidt)
09:45 – 11:00 Treatment of canine high-grade and indolent lymphoma (Schmidt)
11:00 – 11:30 Coffee Break
11:30 – 12:30 Case management: canine lymphoma (Schmidt)
12:30 – 13:45 Lunch Break
13:45 – 14:45 Interactive case session: Do you recognize this disease? (Schmidt)
14:45 – 15:15 Coffee Break
15:15 – 16:15 How to approach lymph node & blood smear cytology (Schmidt)
16:15 – open end Cytology: lymph node cytology & blood smear cases (online self-study)
09:00 – 10:15 Case-based: canine oral tumours (Selmic)
10:15 – 11:00 Case-based: feline oral tumours (Selmic)
11:00 – 11:30 Coffee Break
11:30 – 12:15 Interactive case management: tumours of the salivary glands (Selmic)
12:15 – 12:45 Interactive case management: esophageal tumours (incl. spirocercosis) (Selmic)
12:45 – 14:15 Lunch Break
14:15 – 15:30 Case management: canine liver tumours (Selmic)
15:30 - 16:00 Coffee break
16:00 - 16:30 Feline hepatosplenic tumours (Selmic)
16:30 - 17:00 Tumours of the exocrine pancreas (Selmic)
09:00 – 10:30 Canine bone tumours (Selmic)
10:30 – 11:00 Limb sparing for bone tumours (Selmic)
11:00 – 11:30 Coffee Break
11:30 – 12:00 Case management: surgery of axial bone tumours (Selmic)
12:00 – 12:30 Feline bone tumours (Schmidt)
12:30 – 14:00 Lunch Break
14:00 – 15:15 Case management: canine splenic tumours (Schmidt)
15:15 – 15:30 Essentials of splenic tumour surgery (Selmic)
Casus, Exam, Certificate/Master programme (15-30 minutes)
Wrap up of the course
Small Animal Hospital Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok 10330, Thailand
Early registration: Euro 1.350,--
(Deadline for FULL early registration payment: 16 October 2024)
Early registration: Euro 1.750,-
(Deadline for FULL early registration payment: 16 October 2024)
Early registration: Euro 2.250,-
(Deadline for FULL early registration payment: 16 October 2024)
Oncology 5, Xiamen/China, Dr. Schmidt | 09. - 13. Dec 2024 | |
Oncology 2: Hematopoietic Tumours, Tumours of the Digestive Tract & Bone Tumours (Course 2/5), Bangkok/Thailand, Dr. Schmidt | 16. - 20. Dec 2024 | |
Oncology 3: Tumours of the Respiratory and Urogenital Tract, Endocrine & Miscellaneous Tumours (Course 3/5), Shanghai/China, Dr. Schmidt | 31. - 04. Apr 2025 | |
Oncology 1: Tumour Biology, Diagnostic and Treatment Options & Skin Tumours (Course 1/5), TBA/Indonesia, Dr. Schmidt | 18. - 22. Aug 2025 | |
Oncology 3: Tumours of the Respiratory and Urogenital Tract, Endocrine & Miscellaneous Tumours (Course 3/5), TBA/Indonesia, Dr. Schmidt | 24. - 28. Aug 2025 | |
Oncology 1: Tumour Biology, Diagnostic and Treatment Options & Skin Tumours (Course 1/5), TBA/China, Dr. Schmidt | 27. - 31. Oct 2025 |
For payment via Bank Transfer or Paypal please contact the ESAVS Office for Asia: This email address is being protected from spambots. You need JavaScript enabled to view it.
If you have any questions regarding the registration or any other further details for the courses in Asia please contact the ESAVS Office for Asia: This email address is being protected from spambots. You need JavaScript enabled to view it.